Obalon Therapeutics

ReShape Lifesciences, Inc. is a medical device company, which focuses on technology to treat obesity and metabolic diseases. Its portfolio includes the Lap-Band Adjustable Gastric Banding System, ReShape Marketplace, Obalon Balloon System, ReShape Vest, and Diabetes Bloc-Stim Neuromodulation device. The company was founded in December 2002 and is headquartered in San Clemente, CA.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

ReShape Lifesciences, Inc. is a medical device company, which focuses on technology to treat obesity and metabolic diseases. Its portfolio includes the Lap-Band Adjustable Gastric Banding System, ReShape Marketplace, Obalon Balloon System, ReShape Vest, and Diabetes Bloc-Stim Neuromodulation device. It operates through the United States, Australia, Europe, and Rest of World geographical segments. The company was founded in December 2002 and is headquartered in Irvine, CA.

ConforMIS

Clearside Biomedical

Tellurian

Looking for penny stocks to buy on Reddit? Check these 4 out for your watchlist The post 4 Penny Stocks Reddit Traders Are Buying Right Now appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

4 Penny Stocks Reddit Traders Are Buying Right Now

ReShape Lifesciences

SAN CLEMENTE, CA and SAN DIEGO, CA / ACCESSWIRE / June 15, 2021 / ReShape Lifesciences Inc. (OTCQB:RSLS) and Obalon Therapeutics, Inc. (NASDAQ:OBLN) announced today the anticipated closing of their previously announced merger to be effective after the close of the market today, June 15, 2021. The shares of common stock of the combined company are expected to commence trading on The Nasdaq Capital Market on Wednesday, June 16, 2021, under the name ReShape Lifesciences Inc. and the trading symbol "RSLS.

ReShape Lifesciences Inc. and Obalon Therapeutics, Inc. Announce Anticipated Closing of Merger

SAN CLEMENTE, CA and SAN DIEGO, CA / ACCESSWIRE / June 8, 2021 / ReShape Lifesciences Inc. (OTCQB:RSLS) and Obalon Therapeutics, Inc. (NASDAQ:OBLN) announced today that the parties anticipate the closing of their previously announced merger to occur promptly after approval of their pending Nasdaq listing application. While there can be no assurance that the listing application will be approved, Nasdaq approval is the sole remaining condition to closing in the merger agreement (other than conditions that the parties anticipate being satisfied at the closing).

ReShape Lifesciences Inc. and Obalon Therapeutics, Inc. Update on Status of Pending Merger

Ashford Hospitality Trust

Jaguar Health

Are these the best penny stocks to watch right now? Take a look and decide for yourself The post Penny Stocks Are Heating Up, Here's 3 You Need to Know About appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Penny Stocks Are Heating Up, Here's 3 You Need to Know About

The stock price of Obalon Therapeutics Inc (NASDAQ: OBLN) increased by over 20% during intraday trading. This is why it happened.

OBLN Stock Price: Over 20% Increase Explanation

SAN DIEGO, CA / ACCESSWIRE / May 24, 2021 / Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable gas-filled intragastric balloon system for the treatment of obesity, is taking this opportunity to remind its stockholders to vote on all the proposals related to the proposed merger with ReShape Lifesciences Inc. in advance of the upcoming reconvened special meeting of Obalon stockholders (the "Special Meeting") on May 25, 2021, at 8:30 a.m. PT. All stockholders are highly encouraged to vote by phone or email on this critical transaction.

Reminder: Obalon Therapeutics Continues to Urge Stockholders to Vote FOR All Proposals Related to Merger with ReShape Lifesciences

The stock price of Obalon Therapeutics Inc (NASDAQ: OBLN) increased by 30.04% on Friday May 21. This is why it happened.

OBLN Stock Price: 30.04% Increase Explanation

Color Star Technology

Marker Therapeutics Inc

Top penny stocks to buy today? Check these 3 out for your watchlist The post Top Penny Stocks to Buy Today?

Top Penny Stocks to Buy Today? Here's 3 to Watch in 2021

SAN DIEGO, CA / ACCESSWIRE / May 21, 2021 / Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable gas-filled intragastric balloon system for the treatment of obesity, is taking this opportunity to remind its stockholders to vote on all the proposals related to the proposed merger with ReShape Lifesciences Inc. in advance of the upcoming reconvened special meeting of Obalon stockholders (the "Special Meeting") on May 25, 2021, at 8:30 a.m. PT. All stockholders are highly encouraged to vote by phone or email on this critical transaction.

Obalon Therapeutics Continues to Urge Stockholders to Vote FOR All Proposals Related to Merger with ReShape Lifesciences

Urging all Shareholders to Vote For Proposals Related to Merger with ReShape LifeSciences Inc. Meeting to be held via Webcast at 8:30 a.m. Pacific SAN DIEGO, CA / ACCESSWIRE / May 18, 2021 / Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable gas-filled intragastric balloon system for the treatment of obesity, announced that the special shareholders meeting for Obalon Stockholders (the "Special Meeting") on May 13, 2021 was convened without a quorum and adjourned until Tuesday, May 25, 2021 at 8:30 a.m.

Obalon Therapeutics Stockholders Special Meeting Adjourned to May 25, 2021

Ebang International Holdings

MoSys

Nokia

Precipio

China Rapid Finance

Is finding penny stocks to buy in May 2021? Take a look at these 3 industries for some inspiration The post Which Penny Stocks Are The Most Resilient During a Bear Market?

Which Penny Stocks Are The Most Resilient During a Bear Market?

The stock price of Obalon Therapeutics Inc (NASDAQ: OBLN) increased by over 7% during intraday trading. This is why it happened.

OBLN Stock: Over 7% Increase Intraday Explanation

Evofem Biosciences Inc

Minerva Neurosciences

Novan

Biotech penny stocks are heating up right now; here's 4 to watch The post Best Biotech Penny Stocks to Buy Under $5? 4 To Check Out in May appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Best Biotech Penny Stocks to Buy Under $5? 4 To Check Out in May

SAN DIEGO, May 12, 2021 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled intragastric balloon system for the treatment of obesity, today announced its financial results for the first quarter ended March 31, 2021. On January 19, 2020 the Company signed a definitive agreement for a merger with ReShape Lifesciences Inc.

Obalon Announces First Quarter 2021 Financial Results

SAN DIEGO, CA / ACCESSWIRE / May 12, 2021 / Obalon Therapeutics, Inc. (NASDAQ:OBLN) is urging its stockholders to IMMEDIATELY vote FOR the proposals put forth in its proxy statement to be voted on at the May 13, 2021 special meeting of stockholders, all of which relate to the proposed merger with ReShape Lifesciences Inc., a global weight-loss solutions company offering an integrated portfolio of proven products and services that manage and treat obesity and associated metabolic disease. "We are urging all of our stockholders to take a few minutes to vote by phone or email on this important transaction," said Obalon CEO Andrew Rasdal.

Obalon Therapeutics, Inc. Urges Stockholders to IMMEDIATELY Vote FOR All Proposals Related to the Merger with ReShape Lifesciences Inc

Timber Pharmaceuticals

TETRA Technologies

Before investing in penny stocks, take a look at these 3 things The post Investing in Penny Stocks? Don't Before You Do These 3 Things appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Investing in Penny Stocks? Don't Before You Do These 3 Things

iBio

Protagenic Therapeutics

These biotech penny stocks pushed up big today; but are they worth it? The post 4 Biotech Penny Stocks That You Need to Know About appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

4 Biotech Penny Stocks That You Need to Know About

Cellect Biotechnology Ltd

CKX Lands

Cue Biopharma

Eltek

SemiLEDs

PolarityTE Inc

Regional Health Properties

Joins us as we take a look at the most volatile stocks for Monday as many shares see their prices fluctuate during the day. The post Market Update: The 10 Most Volatile Stocks Today appeared first on InvestorPlace.

Market Update: The 10 Most Volatile Stocks Today

Vinco Ventures

Foresight Autonomous Hlds

Reddit penny stocks remain popular, here's 3 to watch The post Top Reddit Penny Stocks To Buy Today? 3 To Watch Right Now appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Top Reddit Penny Stocks To Buy Today? 3 To Watch Right Now

Moxian BVI

SeaChange International

Penny stocks are benefitting from the cryptocurrency boom; here's 3 to watch The post Penny Stocks to Buy During the Cryptocurrency Boom? Here's 3 to Watch appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Penny Stocks to Buy During the Cryptocurrency Boom? Here's 3 to Watch

SAN DIEGO, March 12, 2021 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled intragastric balloon system for the treatment of obesity, today announced its financial results for the fourth quarter and full year ended December 31, 2020. On November 10, 2020, the Company signed a non-binding term sheet for merger with ReShape Lifesciences Inc. and, on January 20, 2021, announced that a definitive agreement had been signed on January 19, 2020 for a merger with ReShape Lifesciences Inc.

Obalon Announces Fourth Quarter and Full Year 2020 Financial Results

The stock price of Obalon Therapeutics Inc (NASDAQ: OBLN) increased by over 20% pre-market. This is why it happened.

OBL Stock Price Increases Over 20% Pre-Market: Why It Happened

WILMINGTON, Del., Jan. 25, 2021 (GLOBE NEWSWIRE) -- Rigrodsky Law, P.A. announces that it is investigating Obalon Therapeutics, Inc. (“Obalon”) (NASDAQ GS: OBLN) regarding possible breaches of fiduciary duties and other violations of law related to Obalon's agreement to merge with ReShape Lifesciences, Inc.

SHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Investigation of Obalon Therapeutics, Inc. Merger

NEW YORK, Jan. 23, 2021 /PRNewswire/ -- Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm rated Top 50 in the 2018 and 2019 ISS Securities Class Action Services Report and headquartered at the Empire State Building in New York City, is...

SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Obalon Therapeutics, Inc. - OBLN

NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed merger of Obalon Therapeutics, Inc. (NasdaqGS: OBLN) with ReShape Lifesciences Inc. (OTCQB: RSLS) pursuant to which Obalon shareholders will end up owning only approximately 49% of the combined company. If you believe that this transaction undervalues the Company and/or if you would like to discuss your legal rights r

News for Obalon Therapeutics Stock (OBLN)